Robert Gunning

Comptroller/Controller/Auditor at FRAZIER LIFESCIENCES ACQUISITION CORPORATION

55 year

Health Technology

Consumer Services

Profile

Robert W.
Gunning is currently Principal Accounting Officer, VP & Controller at NewAmsterdam Pharma Co. NV since 2026.
Formerly, Mr. Gunning was Controller at Altimmune, Inc. in 2026 and Vice President-Finance & Controller at Y-mAbs Therapeutics, Inc. from 2022 to 2026.
Mr. Gunning completed undergraduate education at Pace University.

Robert Gunning active positions

Companies	Position	Start
FRAZIER LIFESCIENCES ACQUISITION CORPORATION	Comptroller/Controller/Auditor	2026-08-09

All active positions of Robert Gunning

Former positions of Robert Gunning

Companies	Position	End
ALTIMMUNE, INC.	Comptroller/Controller/Auditor	2026-06-30
YMAS THER	Comptroller/Controller/Auditor	2026-03-31

See the detail of Robert Gunning's experience

Training of Robert Gunning

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Gunning's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Pace University Pace University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Y-mAbs Therapeutics, Inc. Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer	Health Technology
Altimmune, Inc. Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals	Health Technology
NewAmsterdam Pharma Co. NV NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases	Health Technology